TS Harihar of HRBV Client Solutions told CNBC-TV18, "Once this market stabilises around 7,400-7,500 levels on the Nifty, we could see the pharmaceutical stocks leading the recovery in the market. Once the pharma stocks lead the recovery, we will be trying to play that by taking an equal position in Sun Pharmaceutical Industries and Lupin. But at the same time we also expect that the non-defensives would keep the Nifty down. So we are hedging that position by selling two lots of Nifty. So essentially it is betting on the pharma sector, outperforming the Nifty overall."At 12:23 hrs Sun Pharmaceutical Industries was quoting at Rs 832.30, down Rs 4.15, or 0.50 percent. It has touched a 52-week low of Rs 815.30.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!